Press Releases
GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine
GSK and Medicago announced a collaboration to develop and evaluate a COVID-19 candidate vaccine combining Medicago’s recombinant Coronavirus Virus-Like Particles (CoVLP) with GSK’s pandemic adjuvant system. CoVLPs mimic the structure of the virus responsible for COVID-19 disease, allowing them...
Drug Research
CIRION BioPharma Research Expands its Bioanalytical Services and Offers SARS-CoV-2 and COVID-19 Antibodies Testing Services
CIRION Research Inc., a leading provider of large molecule bioanalytical testing and global central laboratory services, announced that the company is now offering new testing services for the screening and clinical diagnosis of COVID–19 and expands its existing laboratory...
Press Releases
Fujifilm partners with Dr. Reddys and Global Response Aid for deployment of a COVID-19 treatment drug outside of Japan
FUJIFILM Corporation partners with Dr. Reddy's Laboratories Ltd., a global pharmaceutical company headquartered in India and Global Response Aid, a global provider of medical supplies and pharmaceuticals, aimed at overseas deployment of a treatment drug for the novel coronavirus...
Packaging & Labelling
SCHOTT delivers pharma vials to package 2 billion doses of COVID-19 vaccines
SCHOTT supports the world’s fight against COVID-19 with vials capable of holding up to 2 billion vaccination doses. The glassmaker and pharma packaging specialist has reached agreements with leading pharmaceutical companies, including partners of ‘Operation Warp Speed’ – the...
Packaging & Labelling
DHL and Air France KLM Martinair Cargo Make Transports of medicinal products more transparent
DHL Global Forwarding, the air and ocean freight specialist of Deutsche Post DHL Group, and Air France KLM Martinair (AFKLMP) Cargo improve transparency in the pharmaceutical logistics chain. Together, the two leading players in the airfreight pharmaceutical industry have...
Clinical Trials
India’s 1st COVID-19 Vaccine -COVAXIN, Developed by Bharat Biotech gets DCGI approval for Phase I & II Human Clinical Trials
Bharat Biotech has successfully developed COVAXIN™, India’s 1stvaccine candidate for COVID-19, in collaboration with the Indian Council of Medical Research (ICMR) -National Institute of Virology (NIV). The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech....
Press Releases
Bormioli Pharma invests in Type I glass vial production for injectable medicines and vaccines
The company invested more than 50 million euros in the last months for improving its production platform, including a brand-new glass furnace in Bergantino, the upgrade of the San Vito al Tagliamento glass production, as well as the acquisition...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















